- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02094664
Heated Humidified Oxygen Compared to Dry Oxygen Therapy in Children With Bronchiolitis
HHOT AIR Study (a Pilot Study): Heated Humidified Oxygen Therapy Compared to Standard Dry Oxygen: An Assessment in Infants With bRonchiolitis
The purpose of this study is to compare heat and humidified oxygen with cold and dry oxygen in children with bronchiolitis.
The hypotheses are that heating and humidifying inspired low flow supplemental oxygen will optimize mucociliary function thereby, 1) improve oxygenation, 2) decrease work of breathing, and 3) decrease length of hospital stay.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Bronchiolitis is the leading cause of acute respiratory illness and hospitalization in infants and young children. The mainstay of treatment is supportive care, which includes frequent nasal suctioning, intravenous fluid hydration, and supplemental oxygen for hypoxemia.
The airways normally heat and humidify inspired ambient air to core temperature amd 100% relative humidity at the carina. This environment, at core temperature, allows for optimal mucociliary clearance. Supplemental oxygen delivered via wall source is cold and dry, and does not reach core temperature and 100% humidity until some point distal to the carina, past the main bronchi. This presses on the lower respiratory tract to assist in heat and moisture exchange and thus decrease ciliary function. This, in combination with bronchiolitis, can impair mucociliary clearance.
Specific aim 1: Determine the effect of heated and humidified oxygen therapy on clinical improvement in children with bronchiolitis, based on Respiratory Distress Assessment Instrument (RDAI) and respiratory rate (RR).
Specific aim 2: Determine the effect of heated and humidified oxygen therapy on length of hospital stay and duration of supplemental oxygen requirement in children with bronchiolitis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Oakland, California, United States, 94609
- Children's Hospital and Research Center Oakland
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages ≤24 months of age
- Physician diagnosed bronchiolitis
- Admitted to pediatric floor
- Supplemental oxygen requirement, <4 L/min, for hypoxemia, oxygen saturation <92% in room air
Exclusion Criteria:
- Prematurity, born <37 weeks gestational age
- Admitted to pediatric intensive care unit for medical indication
- Requirement of heated, humidified high flow system
- Chronic lung disease (such as bronchopulmonary dysplasia, cystic fibrosis, primary ciliary dyskinesia, tracheostomy status, baseline oxygen requirement)
- Neuromuscular disorders
- Chromosomal defects
- Metabolic disorders
- Immunodeficiency
- Unrepaired cardiac abnormalities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard oxygen via nasal cannula
Standard therapy
|
|
Active Comparator: Heated and humidified oxygen
Heated and humified oxygen
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Respiratory Distress Assessment Instrument (RDAI) From Baseline.
Time Frame: Baseline, Hour 1, Hour 4, Hour 8, and Hour 12
|
The RDAI is a validated clinical scoring system to assess respiratory distress and has been used in several bronchiolitis studies.
The RDAI is based on two variables, wheezing and retractions, in which points are applied to each to give a score ranging from 0 to 17.
The higher the total score, the worse the subject was clinically.
Reported are the absolute scores at each time point, for each arm.
Baseline scores are reported in the Baseline Module.
|
Baseline, Hour 1, Hour 4, Hour 8, and Hour 12
|
Change in Respiratory Rate (RR) From Baseline
Time Frame: Baseline, Hour 1, Hour 4, Hour 8, and Hour 12
|
Respiratory rate was measured by counting respirations for one minute.
Reported are the absolute scores at each time point, for each arm.
Baseline scores are reported in the Baseline Module.
|
Baseline, Hour 1, Hour 4, Hour 8, and Hour 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of Hospital Stay
Time Frame: Subjects will be followed for the duration of hospital stay until discharge
|
Length of hospital stay is measured in days and counted from day of admission to day of discharge.
|
Subjects will be followed for the duration of hospital stay until discharge
|
Duration of O2 Use
Time Frame: Subjects will be followed for the duration of oxygen requirement until oxygen discontinued
|
Duration on supplemental O2 was measured in hours.
|
Subjects will be followed for the duration of oxygen requirement until oxygen discontinued
|
Collaborators and Investigators
Investigators
- Principal Investigator: Diana Chen, M.D., UCSF Benioff Children's Hospital Oakland
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-066
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiolitis
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft vs Host Disease | Constrictive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Hillel Yaffe Medical CenterCompletedReflexology | Bronchiolitis; ChemicalIsrael
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Ministry of Health, SpainCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Hospices Civils de LyonRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Viral BronchiolitisFrance
-
University Hospital, Basel, SwitzerlandRecruitingBronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)Switzerland, Saudi Arabia
-
Groupe Hospitalier du HavreCompletedAcute Viral BronchiolitisFrance
Clinical Trials on Heated and humidified oxygen
-
University Health Network, TorontoKaiser PermanenteCompletedGastric DistentionCanada
-
Poitiers University HospitalCompletedCardiogenic Pulmonary EdemaFrance
-
Assistance Publique - Hôpitaux de ParisDirection Générale de l'Offre de SoinsCompletedHypercapnic Respiratory FailureFrance
-
Keimyung University Dongsan Medical CenterUnknownTemperature | One-lung Ventilation | Oxygenation
-
McMaster UniversityFisher and Paykel HealthcareActive, not recruiting
-
Sichuan Cancer Hospital and Research InstituteRecruitingGynecologic Surgery | High-flow Nasal Cannula | Post-operative Pulmonary ComplicationsChina
-
University Hospital, Clermont-FerrandCompletedPostoperative HypoxemiaFrance
-
University Hospital, AngersUnknown
-
Johns Hopkins UniversityCompleted
-
Shin Kong Wu Ho-Su Memorial HospitalFu Jen Catholic UniversityCompleted